References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
People living with HIV in the UK today can expect a near-normal lifespan when they are diagnosed early and stay on effective treatment. A 20-year-old starting modern antiretroviral therapy (ART) today is likely to live into their 70s or 80s, similar to the general population. This is one of the biggest changes in medicine over the last three decades.
Here’s what the evidence shows about HIV life expectancy, and the factors that make the biggest difference.
Order a discreet home HIV test
What the Research Shows
Large studies from the UK, Europe and North America consistently show that life expectancy for people with HIV on effective treatment is now close to that of the general population. Key findings include:
- People diagnosed promptly and treated successfully have close to normal life expectancy
- The gap with the general population has narrowed dramatically since the early 2000s
- Newer drug regimens have fewer long-term side effects than older ones
- Smoking and other lifestyle factors now have more impact on life expectancy than HIV itself for most people
Factors That Affect Life Expectancy
| Factor | Impact |
|---|---|
| Starting ART early (before CD4 drops) | Major positive |
| Undetectable viral load | Major positive |
| Late diagnosis (low CD4 at start) | Reduced life expectancy, though still much better than untreated |
| Smoking | Larger impact on lifespan than HIV itself in the modern era |
| Cardiovascular health | Important — HIV slightly raises cardiovascular risk |
| Adherence to treatment | Critical — missed doses allow resistance |
| Mental health and peer support | Strongly affects long-term outcomes |
What About Older People Living with HIV?
The HIV population in the UK is getting older. This brings new challenges — managing cardiovascular disease, cancer screening, bone health, and cognitive changes — many of which are common in ageing generally but slightly more common in people with HIV. UK HIV clinics are increasingly integrated with general healthcare to manage these complex needs.
Things That Improve Long-Term Outcomes
- Take ART every day — consistency matters more than any other factor
- Stop smoking — the single biggest lifestyle win
- Stay active — 150 minutes of moderate exercise per week
- Eat a balanced diet
- Limit alcohol
- Attend all clinic appointments
- Get vaccinated — flu, pneumococcal, COVID-19 boosters
- Look after mental health — depression is common and treatable
Late Diagnosis Is Still the Biggest Risk
The single biggest risk factor for reduced life expectancy with HIV in the UK today is being diagnosed late — when CD4 counts have already dropped significantly. Testing early and getting onto treatment promptly makes the biggest difference to long-term health.
Read more: What is HIV? | HIV and the immune system | Home HIV testing accuracy
Frequently Asked Questions
Can I live a normal life with HIV?
Yes. With modern treatment, most people with HIV live long, healthy lives and have similar life expectancy to the general population.
Does HIV still shorten life?
Only modestly for people diagnosed early and on effective treatment. Late diagnosis or untreated HIV still has a significant impact on life expectancy.
What’s the biggest threat to my health if I have HIV?
In the modern treatment era, smoking and other cardiovascular risk factors are often a bigger threat than HIV itself for people on effective ART. Stopping smoking is the single most impactful change you can make.
Related reading
- Do You Have to Disclose Your HIV Status to an Employer?
- Disclosing Your HIV Status: Who, When and How
- Health Insurance for People with HIV in the UK
- Healthy Eating for People Living with HIV
- HIV Criminalisation Laws Around the World
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data
Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.
